Tony Bradshaw is the Managing Director of Biosocius and MyFuturePlan which operates as a business unit. It is focused on supporting the development of people as individuals or within teams in the biotechnology sector through coaching and assessment staff retention. Most clients have between 5 and 50 staff or are academic institutions. The projects focus on staff engagement, gaps and succession planning, personal development and team dynamics. I am a qualified coach specialising in career… Show more Tony Bradshaw is the Managing Director of Biosocius and MyFuturePlan which operates as a business unit. It is focused on supporting the development of people as individuals or within teams in the biotechnology sector through coaching and assessment staff retention. Most clients have between 5 and 50 staff or are academic institutions. The projects focus on staff engagement, gaps and succession planning, personal development and team dynamics. I am a qualified coach specialising in career development. It has, in the last 7 years coached approximately 600 people and had around 30 corporate and academic clients. For more information visit www.biosocius.com. MyFuturePlan established in 2018 operates as a business unit at Biosocius. It supports graduates/post-graduates, PDRAs and early career researchers in small groups to understand how they navigate their career opportunities. Show less

Delighted to have been part of such a dynamic organisation, with significant activity in both Sweden and the UK and now with Cognate BioServices and the wider Charles River organisation.

An organisation formed from the original KTNs' and funded by Innovate UK. I had a project oriented role with responsibility for Talent Management and the International Programme. I retained an interest in the Biotechnology communities and ran projects at the interface between industry and academia.

The HealthTech and Medicines Knowledge Transfer Network catalysed innovation by connecting companies and the science base, driving science into products and processes. It was primarily funded by Innovate UK and run by bioProcessUK@theBIA and TWI.• Co led the merger of two KTNs to form the successful HealthTech and Medicines KTN raising a further £4m• Established a flexible and motivated resource of > 30 Knowledge Exchange Specialists based throughout the UK• Engaged multiple… Show more The HealthTech and Medicines Knowledge Transfer Network catalysed innovation by connecting companies and the science base, driving science into products and processes. It was primarily funded by Innovate UK and run by bioProcessUK@theBIA and TWI.• Co led the merger of two KTNs to form the successful HealthTech and Medicines KTN raising a further £4m• Established a flexible and motivated resource of > 30 Knowledge Exchange Specialists based throughout the UK• Engaged multiple government departments and industry stakeholders, raising the profile and influence of the KTN leading to significant outcomesi. Initiated the establishment of the National Biologics Manufacturing Centre and the Medicines Manufacturing Industry Partnership in collaboration with the BIAii. Chaired a policy group that initiated a skills voucher scheme for SMEs Show less

bioProcessUK was established to drive the development of UK biopharmaceutical bioprocessing in partnership with Industry, the Research Councils (BRIC), the Technology Strategy Board and through its Annual bioProcessUK Conference – now in its twelfth year. It operated as an autonomous division of the BioIndustry Association focused on delivering the goals of Bioscience 2015 - Recommendation 4. It achieved approx. £1m t/o in 2013/14. Clients, in addition to the Innovate UK KTN grant, included the… Show more bioProcessUK was established to drive the development of UK biopharmaceutical bioprocessing in partnership with Industry, the Research Councils (BRIC), the Technology Strategy Board and through its Annual bioProcessUK Conference – now in its twelfth year. It operated as an autonomous division of the BioIndustry Association focused on delivering the goals of Bioscience 2015 - Recommendation 4. It achieved approx. £1m t/o in 2013/14. Clients, in addition to the Innovate UK KTN grant, included the Catapults, Universities, Industry and Research Councils. This was achieved through an intrapreneurial and trusted team established from scratch.• Commercial Director at the BIA (10 people, £1.5 million t/o) for two years and member of BIA leadership team, attending BIA Board meetings, for 9 years.• Led the development of bioleadership skills policy featured in the UK Governments Autumn 2011 announcements on Life Sciences • Established the BIA Mentoring Programme which featured in the IOD's Director magazine• Raised £1 million from an 18 company consortia to leverage a further £10 million from Research Councils (BRIC)• Raised £3 million of funding to implement the UK Bioprocessing strategy• Lead all operational matters outsourcing finance, IT and HR• Kept bioprocessing on the governments agenda leading to the MMIP, NBMC and a future that will transform bioprocessing status and investment in the UK Show less

Focused on recruiting management teams for European biotechnology companies, becoming a market leading recruiter in biopharmaceutical development and manufacturing, knowledge transfer and business development positions.

• Built an outstanding network and profile for the Institute with articles published in the Financial Times, Science and Nature Biotechnology• Built a world-class training programme (MBI Training) for industrialists, which sold to more than 300 people from over 100 companies in all continents within 5 years. Now entering its 20th year. • Resulting industrial collaboration mechanism was highly rated by the institutes funding body (BBSRC) bringing 750 industrial visitors annually and… Show more • Built an outstanding network and profile for the Institute with articles published in the Financial Times, Science and Nature Biotechnology• Built a world-class training programme (MBI Training) for industrialists, which sold to more than 300 people from over 100 companies in all continents within 5 years. Now entering its 20th year. • Resulting industrial collaboration mechanism was highly rated by the institutes funding body (BBSRC) bringing 750 industrial visitors annually and provided the foundation for £million awards in research and education. Show less

Initially a research scientist moving into business development focusing on evaluating biotechnology opportunities.